• Home >
  • Scientific Events >
  • The emerging immunogenomic landscape of uveal melanoma and therapeutic implications

The emerging immunogenomic landscape of uveal melanoma and therapeutic implications

21 March - 17h15 - 23h59

Centre de recherche - Paris

Amphithéâtre Constant-Burg - 12 rue Lhomond, Paris 5e

12 rue Lhomond, Paris 5ème

Description

Uveal melanoma responds poorly to checkpoint inhibitor immunotherapy, which has been attributed to low mutation burden. Additionally, there is growing evidence that uveal melanomas actively suppress the tumor immune microenvironment via recurrent genetic aberrations such as BAP1 mutations. The role of recurrent genetic aberrations in immune evasion and potential therapeutic strategies will be discussed.

 

The seminar will also be broadcasted online via Teams

Speakers

J. William Harbour

UT Southwestern Medical Center

Invited by

The Uveal Melanoma Medico-Scientific Program

A question about the seminar?

The Uveal Melanoma Medico-Scientific Program

leanne.de-koning@curie.fr